Harrow (HROW) EBITDA Margin (2013 - 2026)
Harrow (HROW) recorded quarterly EBITDA Margin of 49.95% in Q1 2026, down 385.44% quarter-over-quarter from 17.5% in Q4 2025, and down 2647.0% on a YoY basis from 1.96% in Q1 2025.
Harrow (HROW) EBITDA Margin (2013 - 2026) Analysis & Trends
Harrow's EBITDA Margin history runs 14 years deep, the most recent figure standing at 49.95% for Q1 2026.
- In Q1 2026, EBITDA Margin fell 2647.0% year-over-year to 49.95%; the TTM figure through Mar 2026 stood at 7.32% (up 520.0% YoY), while the FY2025 annual figure was 11.21%, up 679.0% from the prior year.
- EBITDA Margin was 49.95% for Q1 2026 at Harrow, down from 17.5% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 20.59% in Q3 2025 to a low of 49.95% in Q1 2026.
- Historically, EBITDA Margin has averaged 0.08% across 5 years, with a median of 4.64% in 2023.
- The sharpest annual moves came in 2024 and 2026: EBITDA Margin jumped 3271 bps in 2024, then slumped 2647 bps in 2026.
- A 5-year view of EBITDA Margin shows it stood at 8.75% in 2022, then plunged by 53 bps to 13.41% in 2023, then jumped by 244 bps to 19.3% in 2024, then decreased by 9 bps to 17.5% in 2025, then plunged by 385 bps to 49.95% in 2026.
- The last three EBITDA Margin figures came in at 49.95% (Q1 2026), 17.5% (Q4 2025), and 20.59% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -1.01% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 22.74% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -170.35% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 21.55% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -16.25% |
| 10 | Harrow | 1.23 Bn | 1.14 Bn | 27.05 Mn | -49.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.95% |
| Dec 31, 2025 | 17.50% |
| Sep 30, 2025 | 20.59% |
| Jun 30, 2025 | 17.90% |
| Mar 31, 2025 | -23.48% |
| Dec 31, 2024 | 19.30% |
| Sep 30, 2024 | 2.68% |
| Jun 30, 2024 | 3.13% |
| Mar 31, 2024 | -20.03% |
| Dec 31, 2023 | -13.41% |
| Sep 30, 2023 | 5.09% |
| Jun 30, 2023 | 7.03% |
| Mar 31, 2023 | 4.64% |
| Dec 31, 2022 | -8.75% |
| Sep 30, 2022 | -0.41% |
| Jun 30, 2022 | 7.25% |
| Mar 31, 2022 | 9.50% |
| Dec 31, 2021 | -8.69% |
| Sep 30, 2021 | -19.87% |
| Jun 30, 2021 | 22.99% |